1. Management and outcomes of non–small cell lung cancer patients with rapid progression under second‐or‐more‐line immune checkpoint inhibitors: ERORECI study (GFPC 2016‐04). (20th November 2019) Authors: Vergnenegre, Alain; Geier, Margaux; Guisier, Florian; Lamy, Regine; Comet, Bénédicte; Le Garff, Gwenaelle; Do, Pascal; Janicot, Henri; Morel, Hugues; Decroisette, Chantal; Andre, Michel; Falchero, Lionel; Paleiron, Nicolas; Monnet, Isabelle Journal: Cancer medicine Issue: Volume 9:Number 2(2020) Page Start: 432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Economic Analysis of First‐Line Treatment with Erlotinib in anEGFR‐Mutated Population with Advanced NSCLC. Issue 6 (June 2016) Authors: Vergnenegre, Alain; Massuti, Bartomeu; de Marinis, Filippo; Carcereny, Enric; Felip, Enriqueta; Do, Pascal; Sanchez, Jose Miguel; Paz‐Arez, Luis; Chouaid, Christos; Rosell, Rafael Journal: Journal of thoracic oncology Issue: Volume 11:Issue 6(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Utility of serum anti‐cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab. (24th October 2016) Authors: Dupont, Benoît; Mariotte, Delphine; Dugué, Audrey E.; Clarisse, Bénédicte; Grellard, Jean‐Michel; Babin, Emmanuel; Chauffert, Bruno; Dakpé, Stéphanie; Moldovan, Cristian; Bouhier‐Leporrier, Karine; Reimund, Jean‐Marie; Di Fiore, Frederic; Zanetta, Sylvie; Mailliez, Audrey; Do, Pascal; Peytier, An... Journal: British journal of clinical pharmacology Issue: Volume 83:Number 3(2017:Mar.) Page Start: 623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Association between lung cancer somatic mutations and occupational exposure in never-smokers. Issue 4 (26th October 2017) Authors: Paris, Christophe; Do, Pascal; Mastroianni, Bénédicte; Dixmier, Adrien; Dumont, Patrick; Pichon, Eric; Chouaid, Christos; Coudert, Bruno; Foucher, Pascal; Fraboulet, Séverine; Locatelli-Sanchez, Myriam; Baize, Nathalie; Dansin, Eric; Moreau, Lionel; Vincent, Michel; Missy, Pascale; Morin, Franck;... Other Names: author non-byline.; Souquet Pierre-Jean author non-byline.; Gervais Radj author non-byline.; Doubre Hélène author non-byline.; Pichon Eric author non-byline.; Dixmier Adrien author non-byline.; Monnet Isabelle author non-byline.; Mastroianni Bénédicte author non-byline.; Vincent Michel author no... Journal: European respiratory journal Issue: Volume 50:Issue 4(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Real-life experience of ceritinib in crizotinib-pretreated ALK+ advanced non-small cell lung cancer patients. Issue 1 (13th February 2018) Authors: Cadranel, Jacques; Cortot, Alexis B.; Lena, Hervé; Mennecier, Bertrand; Do, Pascal; Dansin, Eric; Mazieres, Julien; Chouaid, Christos; Perol, Maurice; Barlesi, Fabrice; Robinet, Gilles; Friard, Sylvie; Thiberville, Luc; Audigier-Valette, Clarisse; Vergnenegre, Alain; Westeel, Virginie; Slimane, K... Journal: ERJ open research Issue: Volume 4:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world setting. Issue 2 (August 2015) Authors: Sassier, Marion; Dugué, Audrey Emmanuelle; Clarisse, Bénédicte; Lesueur, Paul; Avrillon, Virginie; Bizieux-Thaminy, Acya; Auliac, Jean-Bernard; Kaluzinski, Laure; Tillon, Julie; Robinet, Gilles; Le Caer, Hervé; Monnet, Isabelle; Madroszyk, Anne; Boza, Gabriella; Falchero, Lionel; Fournel, Pierre;... Journal: Lung cancer Issue: Volume 89:Issue 2(2015:Aug.) Page Start: 161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK-positive non–small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria. (September 2017) Authors: Gandhi, Leena; Ou, Sai-Hong Ignatius; Shaw, Alice T.; Barlesi, Fabrice; Dingemans, Anne-Marie C.; Kim, Dong-Wan; Camidge, D. Ross; Hughes, Brett G.M.; Yang, James C.-H.; de Castro, Javier; Crino, Lucio; Léna, Hervé; Do, Pascal; Golding, Sophie; Bordogna, Walter; Zeaiter, Ali; Kotb, Ahmed; Gadgeel... Journal: European journal of cancer Issue: Volume 82(2017) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗